"Revenues from the Molecular Diagnostics Division in the financial year ending 31 December 2006 will not be significant".
The above comment from omh in the recent rns Disposal news, doesn’t give investors much confidence with any trading update we may get, for the Molecular Diagnostics Division. Could also be one of the reasons for the recent drop in share price, following the news.
With results close on three months away, I can only see this going lower in the near term.
Osmetech stock quotes
Osmetech stock charts
Follow this thread
